Company news
Todos Medical Ltd. news in 2020
Todos Medical Ltd.'s news releases, calls and decks from 2020, newest first.
Todos Medical Announces Agreement to Supply Natural Wellness Clinics with COVID-19 Testing Products to Support Initiatives in the Commonwealth of Kentucky
December 23, 2020
Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore™ for COVID-19 Immune Monitoring Service
December 14, 2020
Todos Medical Announces $3.2 Million in Sales for November 2020, a 269% Increase Sequential Month over Month Sales Growth from October 2020
December 2, 2020
Todos Medical Provides Strategic Outlook
December 1, 2020
Todos Medical Completes Installation of Lab Automation Equipment at Wisconsin Lab Client to Support COVID-19 PCR Testing
November 24, 2020
Todos Medical Announces Positive In Vitro Data for Tollovid™ Confirming 3CL Protease Inhibition Mechanism of Action
November 20, 2020
Todos Medical Announces Positive Initial Clinical Proof-of-Concept Data for a Rapid SARS-CoV-2 3CL Protease Detection Assay
November 18, 2020
Todos Medical Announces Clinical Validation and National CLIA Certification for MOTO+PARA Mobile High Complexity Labs
November 17, 2020
Todos Medical CEO Provides Corporate Update
November 13, 2020
Todos Medical Announces $867,000 in Sales for October 2020
November 12, 2020
Todos Medical Trademarks Tollovid for Dietary Supplement NLC-001 and Enters Into Private Label & Distribution Agreement With The Alchemists Kitchen
October 29, 2020
Todos Medical Announces Instrument Validation Complete at MOTO+PARA Mobile Lab
October 26, 2020
Todos Medical Announces Distribution Agreement with Adial Pharmaceuticals to Market the FDA, EUA Authorized, Assure/FaStep Point-of-Care Covid-19 Antibody Tests
October 22, 2020
Todos Medical Receives Notices of Allowance From the European Patent Office Covering Use of TBIA Cancer Platform to Detect Benign Colon Cancer
October 20, 2020
UPDATE: Todos Medical Reports $2.0 Million in Revenue for the Third Quarter of 2020
October 14, 2020
Todos Medical Reports $2.0 Million in Revenue for the Third Quarter of 2020
October 13, 2020
Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARA’s National Mobile CLIA Lab Partner Integrated Health
October 7, 2020
Todos Medical Enters into Exclusive Branding and Distribution Agreement with Melbourne Biotech for 96 and 384 Well RT-PCR Machines in the United States
September 30, 2020
Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics
September 25, 2020
Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & Supplies with Wisconsin-based Laboratory to $47.5 Million
September 22, 2020
Todos Medical CEO Releases Letter to Shareholders
September 18, 2020
3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma
September 17, 2020
Todos Medical Expands Partnership with Care G.B. Plus for Proprietary TBIA Cancer Tests to Include Europe, Israel and Africa
September 16, 2020
Todos Medical Announces Commercial Launch of Todos Branded COVID-19 qPCR Test Kits in the United States
September 11, 2020
Todos Medical Announces August Sales of $1,190,000, Up 100% Compared with July
September 3, 2020
Todos Medical Enters Into Partnership With Pangea for COVID-19 Testing and Contact Tracing
September 2, 2020
Todos Medical to Present at The LD 500 Virtual Conference
August 30, 2020
Todos Medical Announces $23,760,000 Contract for COVID-19 PCR Testing Equipment & Supplies With Wisconsin-based Laboratory
August 31, 2020
Todos Medical Announces $4,500,000 Contract for COVID-19 PCR Testing Equipment & Supplies with New York-based Laboratory
August 27, 2020
Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations
August 25, 2020
Todos Medical Announces $1.2 Million Contract for COVID-19 PCR Testing Equipment & Supplies with Texas-based Laboratory
August 24, 2020
Todos Medical Announces $6,000,000 Contract for COVID-19 PCR Testing Equipment & Supplies with New York-based Laboratory
August 21, 2020
Todos Medical Announces Positive Proof-of-Concept Data for Novel 10-Minute Point-of-Care Saliva-based Test Detecting Active SARS-CoV-2 Infection
August 17, 2020
Todos Medical Expands Management Team and Advisory Board
July 20, 2020
Todos Medical Enters Into Distribution Partnership With Meridian Health Services Network for COVID-19 Testing Solutions
June 29, 2020
Todos Medical Enters Into Exclusive Distribution Agreement With NLC Pharma for Saliva-based Onsite COVID-19 Diagnostic Test
June 16, 2020
Todos Medical Enters Into Direct Exclusive Distribution Agreement With Gnomegen and Announces US FDA Emergency Use Authorization for its COVID-19 qPCR Test Kits
May 11, 2020
Todos Medical Appoints Dr. Lauren Chung to its Board of Directors
April 17, 2020
Todos Medical Provides Corporate Update
April 9, 2020
Todos Medical Signs Novel Coronavirus (COVID-19) Point-of-Care Rapid Antibody Testing Kit Exclusive Distribution Agreement for the United States and Israel with Shanghai Liangrun Subsidiary Gibraltar
March 19, 2020
Todos Medical Announces Publication Demonstrating Potential of FTIR Platform to Identify Bacterial and Viral Infections
March 2, 2020
Todos Medical Announces Legacy Convertible Note Extension, Lock-Up Agreements, and New Debt Financing
February 25, 2020
Todos Medical Receives Notice of Allowance from European Patent Office Covering Diagnosis of Solid Tumors Using AI to Analyze Blood
February 19, 2020
Todos Medical Releases Letter to Shareholders
February 7, 2020
Todos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics and Announces Management Changes
January 9, 2020
Decks in 2020
- LD Micro (December 2020)
Conference · 15 slides · Dec 15, 2020